A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer

NCT07535463 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Ivonescimab
RADIATION: Stereotactic Radiosurgery

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]